
# Title 42 - Public Health
## Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services
### Subchapter A - General Provisions
#### PART 403 - SPECIAL PROGRAMS AND PROJECTS
##### Subpart I - Transparency Reports and Reporting of Physician Ownership or Investment Interests
###### ยง 403.904 Reports of payments or other transfers of value to covered recipients.
####### clinicaltrials.gov

(A) If the marketed name has not yet been selected, applicable manufacturers must indicate the name registered on.

(B) Any regularly used identifiers must be reported, including, but not limited to, national drug codes.

(ii) For devices, if the device has a unique device identifier (UDI), then the device identifier (DI) portions of it must be reported, as applicable.

(iii) Applicable manufacturers may report the marketed name and therapeutic area or product category for payments or other transfers of value related to a non-covered drug, device, biological, or medical supply.

(iv) Applicable manufacturers must indicate if the related drug, device, biological, or medical supply is covered or non-covered.

(v) Applicable manufacturers must indicate if the payment or other transfer of value is not related to any covered or non-covered drug, device, biological or medical supply.
